The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transoral robotic surgery (TORS)-guided radiotherapy (RT) volume de-intensification in p16-positive unknown primary squamous cell carcinoma (SCC) of the neck: A phase 2 trial (FIND).
 
John R de Almeida
No Relationships to Disclose
 
David Paul Goldstein
Stock and Other Ownership Interests - Pfizer (I)
 
Rosemary Martino
No Relationships to Disclose
 
Jie Su
No Relationships to Disclose
 
Ali Hosni
(OPTIONAL) Uncompensated Relationships - Elekta
 
Scott Victor Bratman
Employment - Adela
Leadership - Adela
Stock and Other Ownership Interests - Adela
Research Funding - Nektar
Patents, Royalties, Other Intellectual Property - Co-inventor and holder of a patent related to circulating tumor DNA detection technology.; Co-inventor of patents related to cell-free DNA methylation analysis technology. (Inst)
 
Douglas Brian Chepeha
No Relationships to Disclose
 
John Waldron
No Relationships to Disclose
 
Ilan Weinreb
No Relationships to Disclose
 
Bayardo Perez-Ordonez
No Relationships to Disclose
 
Eugene Yu
No Relationships to Disclose
 
Ur Metser
Employment - POINT Biopharma
Consulting or Advisory Role - POINT Biopharma
 
Aaron Richard Hansen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Merck; Novartis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Neoleukin Therapeutics (Inst); Pfizer/EMD Serono (Inst); Roche/Genentech (Inst)
 
Wei Xu
No Relationships to Disclose
 
John Kim
Stock and Other Ownership Interests - Immvue Therapeutics